growth/size/body
N |
• weight gain monitored over 8-week period and body length of mutants after cre induction by intracerebroventricular injection of doxycycline is not different from treated controls or wild-type mice
|
• by whole body densitometry (DEXA), whole body fat mass in doxycycline-treated females is increased compared to wild-type controls; however, expressed as percent body weight, whole fat mass in doxycycline-treated females is not different from saline-treated mutant females
|
• analyses over a 2-day period by indirect calorimetry show that male mutants (after cre induction) display a significant increase in body weight compared to treated controls; this transient, significant positive weight gain is observed in females also
|
adipose tissue
• by whole body densitometry (DEXA), whole body fat mass in doxycycline-treated females is increased compared to wild-type controls; however, expressed as percent body weight, whole fat mass in doxycycline-treated females is not different from saline-treated mutant females
|
• doxycycline-treated females show a trend to reduced total fat (white adipose tissue) mass (as % body weight), but also display a trend to increased percent adiposity (total WAT weight compared to wild-type controls) suggesting an increase in relative fat mass
• this is not observed in males
|
• total mass of dissected white adipose tissue depots is increased (as % body weight) in doxycycline-treated females compared to saline-treated females
• this is not observed in males
|
behavior/neurological
N |
• no alterations in food intake in 15-week old mutants of either sex is observed with cre induction by intracerebroventricular injection of doxycycline; spontaneous food intake and intake after 24-hour fasting is similar to dox- or saline-treated controls and wild-type
• over a 2-day period as measured by indirect calorimetry after cre induction, male mutants show trend toward increased food intake relative to controls, but females do not
|
• after cre induction, females exhibit significantly decreased physical activity over a 2-day period relative to controls
• treated males do not show any alteration in activity
|
skeleton
• doxycycline-treated mice show (slight (1.2-fold) but) significant increase in trabecular bone volume as well as trabecular number as determined by micro-CT scan analyses, without change in trabecular thickness
• no differences in cortical bone thickness or volume in distal femur is observed in dox-treated mice compared with controls
|
homeostasis/metabolism
• after cre induction, male mutants show trend toward decreased rectal temperature (and increased food intake) relative to controls
• females do not, although the transient weight gain is observed
|
• analyses over a 2-day period by indirect calorimetry show that female mutants after cre induction) display a significant increase in oxygen consumption notably during light phase with no change in the dark phase
• male mice do not show this or change in respiratory exchange ratio (RER)
|
• doxycycline-treated females show improved fasting glycemia compared to controls
• doxycycline-treated males do not show this phenotype
|
• doxycycline-treated females show an increase in hepatic triglyceride content compared to saline-treated females; in males, triglyceride content is significantly decreased
|
liver/biliary system
• doxycycline-treated females show an increase in hepatic triglyceride content compared to saline-treated females; in males, triglyceride content is significantly decreased
|
renal/urinary system
N |
• daily water intake in mutants after with cre induction by intracerebroventricular injection of doxycycline is not different from control
|